Tenecteplase Non-inferior to Alteplase in Stroke: ATTEST-2

This result, along with its ease of use, adds to the growing evidence that tenecteplase should be a first-line thrombolytic agent, trial investigators say.

Related Keywords

Toronto ,Ontario ,Canada ,China ,United Kingdom ,Chinese ,Raul Nogueira ,Keith Muir ,University Of Pittsburgh School Medicine ,University Of Pittsburgh ,University Of Glasgow ,World Stroke Conference ,Medscape Cardiology ,Pittsburgh School ,Rankin Scale ,Stroke ,Erebrovascular Accident ,Va Cerebrovascular Accident ,Thromboembolism ,Mechanical Thrombolysis In Acute Stroke ,Cute Stroke Mechanical Thrombolysis ,Troke Acute Mechanical Thrombolysis ,Thrombolytic Therapy ,Hospitals ,Ischemic Stroke ,United Kingdom Site Content ,Meta Analysis ,Clinical Research ,Clinical Trials ,Linical Studies ,Heart ,Hemorrhage ,Bleeding ,Neurosurgery ,Healthcare And ,